Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in haematopoietic stem cell transplantation for treatment of non-malignant diseases
Published in 2007 by
O. Ringden,
M. Remberger,
P. Svenberg,
B. Svahn,
G. Dahllof,
B. Gustafsson,
Z. Hassan,
B. Omazic,
J. Aschan,
L. Barkholt,
J. Winiarski,
P. Ljungman,
J. Mattsson 
